Answers are grounded in this paper and cite their sources.
Overview · Class: A semisynthetic form of acylaminopenicillin is piperacillin. It is a bactericidal antibiotic with a broad spectrum. · Combination Use: It is frequently used in an 8:1 ratio with the beta-lactamase inhibitor tazobactam. Tazobactam prevents bacterial enzymes (beta-lactamases) from breaking down piperacillin. Mechanism of Action · Cell Wall Synthesis Inhibition: By attaching to penicillin-binding proteins (PBPs), it prevents bacteria from constructing their cell walls, causing cell lysis and death. · Spectrum: It covers a wide range of anaerobic, Gram-positive, and Gram-negative bacteria, including Pseudomonas aeruginosa. Atypical pathogens like Legionella and MRSA are not included. Pharmacokinetics & Elimination · Administration: administered by intramuscular (IM) or intravenous (IV) injection. · Excretion: mostly removed by the kidneys through tubular secretion and renal filtration, with high quantities seen in urine. · Half-life: It is typically between 36 to 72 minutes for adults, however it can be longer for newborns, elderly people, or people with impaired kidney function. Common Indications · Lower respiratory tract and hospital-acquired pneumonia · Intra-abdominal and gastrointestinal infections · Complicated urinary tract infections and pyelonephritis · Skin and soft tissue infections · Gynecological infections and febrile neutropenia Safety & Adverse Effects · Common Side Effects: nausea, diarrhea, upset stomach, and minor skin rashes. · Severe Risks: hypersensitivity reactions, allergic shock, blood disorders (such thrombocytopenia), and uncommon effects on the kidneys or nervous system in susceptible individuals.
No takes yet. Share an insight, caveat, or question.
E. et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: